Nutriband Inc
Follow $NTRB
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $NTRB by emailVeridion Score
BETALOW CONF · 5 of 6 factors measuredHighest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is NTRB moving today?
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. Company operates in two reportable segments namely, Sales of Goods and Services. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
NTRB overview
Related filings and maps
Congress activity in NTRB
No receipt-qualified Congressional disclosure is present for NTRB in the cached public ledger.
NTRB contract awards, year to date.
Public federal awards linked to this ticker.
NTRB lobbying filings, year to date.
Registered lobbying filings matched to Nutriband Inc.